SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "(WFRF:(Johansson Kenneth)) conttype:(refereed) srt2:(2015-2019) "

Search: (WFRF:(Johansson Kenneth)) conttype:(refereed) srt2:(2015-2019)

  • Result 11-20 of 29
Sort/group result
   
EnumerationReferenceCoverFind
11.
  • Fredenberg, Erik, et al. (author)
  • X-ray attenuation of adipose breast tissue : In-vitro and in-vivo measurements using spectral imaging
  • 2015
  • In: MEDICAL IMAGING 2015: PHYSICS OF MEDICAL IMAGING. - : SPIE. - 9781628415025
  • Conference paper (peer-reviewed)abstract
    • The development of new x-ray imaging techniques often requires prior knowledge of tissue attenuation, but the sources of such information are sparse. We have measured the attenuation of adipose breast tissue using spectral imaging, in vitro and in vivo. For the in-vitro measurement, fixed samples of adipose breast tissue were imaged on a spectral mammography system, and the energy-dependent x-ray attenuation was measured in terms of equivalent thicknesses of aluminum and poly-methyl methacrylate (PMMA). For the in-vivo measurement, a similar procedure was applied on a number of spectral screening mammograms. The results of the two measurements agreed well and were consistent with published attenuation data and with measurements on tissue-equivalent material.
  •  
12.
  • Gunst, Annika, et al. (author)
  • A study of possible associations between single nucleotide polymorphisms in the estrogen receptor 2 gene and female sexual desire.
  • 2015
  • In: The journal of sexual medicine. - : Oxford University Press (OUP). - 1743-6109 .- 1743-6095. ; 12:3, s. 676-84
  • Journal article (peer-reviewed)abstract
    • Female sexual desire and arousal problems have been shown to have a heritable component of moderate size. Previous molecular genetic studies on sexual desire have mainly focused on genes associated with neurotransmitters such as dopamine and serotonin. Nevertheless, there is reason to believe that hormones with more specific functions concerning sexuality could have an impact on sexual desire and arousal.
  •  
13.
  • Haycock, Philip C., et al. (author)
  • Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases A Mendelian Randomization Study
  • 2017
  • In: JAMA Oncology. - : American Medical Association. - 2374-2437 .- 2374-2445. ; 3:5, s. 636-651
  • Journal article (peer-reviewed)abstract
    • IMPORTANCE: The causal direction and magnitude of the association between telomere length and incidence of cancer and non-neoplastic diseases is uncertain owing to the susceptibility of observational studies to confounding and reverse causation. OBJECTIVE: To conduct a Mendelian randomization study, using germline genetic variants as instrumental variables, to appraise the causal relevance of telomere length for risk of cancer and non-neoplastic diseases. DATA SOURCES: Genomewide association studies (GWAS) published up to January 15, 2015. STUDY SELECTION: GWAS of noncommunicable diseases that assayed germline genetic variation and did not select cohort or control participants on the basis of preexisting diseases. Of 163 GWAS of noncommunicable diseases identified, summary data from 103 were available. DATA EXTRACTION AND SYNTHESIS: Summary association statistics for single nucleotide polymorphisms (SNPs) that are strongly associated with telomere length in the general population. MAIN OUTCOMES AND MEASURES: Odds ratios (ORs) and 95% confidence intervals (CIs) for disease per standard deviation (SD) higher telomere length due to germline genetic variation. RESULTS: Summary data were available for 35 cancers and 48 non-neoplastic diseases, corresponding to 420 081 cases (median cases, 2526 per disease) and 1 093 105 controls (median, 6789 per disease). Increased telomere length due to germline genetic variation was generally associated with increased risk for site-specific cancers. The strongest associations (ORs [ 95% CIs] per 1-SD change in genetically increased telomere length) were observed for glioma, 5.27 (3.15-8.81); serous low-malignant-potential ovarian cancer, 4.35 (2.39-7.94); lung adenocarcinoma, 3.19 (2.40-4.22); neuroblastoma, 2.98 (1.92-4.62); bladder cancer, 2.19 (1.32-3.66); melanoma, 1.87 (1.55-2.26); testicular cancer, 1.76 (1.02-3.04); kidney cancer, 1.55 (1.08-2.23); and endometrial cancer, 1.31 (1.07-1.61). Associations were stronger for rarer cancers and at tissue sites with lower rates of stem cell division. There was generally little evidence of association between genetically increased telomere length and risk of psychiatric, autoimmune, inflammatory, diabetic, and other non-neoplastic diseases, except for coronary heart disease (OR, 0.78 [ 95% CI, 0.67-0.90]), abdominal aortic aneurysm (OR, 0.63 [ 95% CI, 0.49-0.81]), celiac disease (OR, 0.42 [ 95% CI, 0.28-0.61]) and interstitial lung disease (OR, 0.09 [ 95% CI, 0.05-0.15]). CONCLUSIONS AND RELEVANCE: It is likely that longer telomeres increase risk for several cancers but reduce risk for some non-neoplastic diseases, including cardiovascular diseases.
  •  
14.
  •  
15.
  • Joensuu, Heikki, et al. (author)
  • Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer The SOLD Randomized Clinical Trial
  • 2018
  • In: JAMA Oncology. - : AMER MEDICAL ASSOC. - 2374-2437 .- 2374-2445. ; 4:9, s. 1199-1206
  • Journal article (peer-reviewed)abstract
    • Importance: Trastuzumab plus chemotherapy is the standard adjuvant treatment for patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer. While the standard duration of trastuzumab treatment is 12 months, the benefits and harms of trastuzumab continued beyond the chemotherapy are unclear.Objective: To evaluate the efficacy and safety of adjuvant trastuzumab continued beyond chemotherapy in women treated with up-front chemotherapy containing a taxane and trastuzumab.Design, Setting, and Participants: Open-label, randomized (1:1) clinical trial including women with HER2-positive breast cancer. Chemotherapy was identical in the 2 groups, consisting of 3 cycles of 3-weekly docetaxel (either 80 or 100 mg/m2) plus trastuzumab for 9 weeks, followed by 3 cycles of fluorouracil, epirubicin, and cyclophosphamide. Thereafter, no trastuzumab was administered in the 9-week group, whereas controls received trastuzumab to complete 1 year of administration. Disease-free survival (DFS) was compared between the groups using a Cox model and the noninferiority approach. The estimated sample size was 2168 patients (1-sided testing, with a relative noninferiority margin of 1.3). From January 3, 2008, to December 16, 2014, 2176 patients were accrued from 7 countries.Intervention: Docetaxel plus trastuzumab for 9 weeks, followed by 3 cycles of fluorouracil, epirubicin, and cyclophosphamide in both groups. Controls continued trastuzumab to 1 year.Main Outcomes and Measures: The primary objective was DFS; secondary objectives included distant disease–free survival, overall survival, cardiac DFS, and safety.Results: In the 2174 women analyzed, median age was 56 (interquartile range [IQR], 48-64) years. The median follow-up was 5.2 (IQR, 3.8-6.7) years. Noninferiority of the 9-week treatment could not be demonstrated for DFS (hazard ratio, 1.39; 2-sided 90% CI, 1.12-1.72). Distant disease–free survival and overall survival did not differ substantially between the groups. Thirty-six (3%) and 21 (2%) patients in the 1-year and the 9-week groups, respectively, had cardiac failure; the left ventricle ejection fraction was better maintained in the 9-week group. An interaction was detected between the docetaxel dose and DFS; patients in the 9-week group treated with 80 mg/m2 had inferior and those treated with 100 mg/m2 had similar DFS as patients in the 1-year group.Conclusions and Relevance: Nine weeks of trastuzumab was not noninferior to 1 year of trastuzumab when given with similar chemotherapy. Cardiac safety was better in the 9-week group. The docetaxel dosing with trastuzumab requires further study.Trial Registration: ClinicalTrials.gov Identifier: NCT00593697
  •  
16.
  •  
17.
  • Johansson, Roger, et al. (author)
  • Gaze patterns reveal how situation models and text representations contribute to episodic text memory
  • 2018
  • In: Cognition. - : Elsevier BV. - 0010-0277. ; 175, s. 53-68
  • Journal article (peer-reviewed)abstract
    • When recalling something you have previously read, to what degree will such episodic remembering activate a situation model of described events versus a memory representation of the text itself? The present study was designed to address this question by recording eye movements of participants who recalled previously read texts while looking at a blank screen. An accumulating body of research has demonstrated that spontaneous eye movements occur during episodic memory retrieval and that fixation locations from such gaze patterns to a large degree overlap with the visuospatial layout of the recalled information. Here we used this phenomenon to investigate to what degree participants’ gaze patterns corresponded with the visuospatial configuration of the text itself versus a visuospatial configuration described in it. The texts to be recalled were scene descriptions, where the spatial configuration of the scene content was manipulated to be either congruent or incongruent with the spatial configuration of the text itself. Results show that participants’ gaze patterns were more likely to correspond with a visuospatial representation of the described scene than with a visuospatial representation of the text itself, but also that the contribution of those representations of space is sensitive to the text content. This is the first demonstration that eye movements can be used to discriminate on which representational level texts are remembered and the findings provide novel insight into the underlying dynamics in play.
  •  
18.
  • Kalland, Kristine, et al. (author)
  • Similar outcome of femoral neck fractures treated with Pinloc or Hansson Pins: 1-year data from a multicenter randomized clinical study on 439 patients
  • 2019
  • In: Acta Orthopaedica. - : Medical Journals Sweden AB. - 1745-3674 .- 1745-3682. ; 90:6, s. 542-546
  • Journal article (peer-reviewed)abstract
    • Background and purpose - There are few reports on the efficiency of the Hansson Pinloc System (Pinloc) for fixation of femoral neck fractures. We compare Pinloc with the commonly used Hansson Pin System in a randomized clinical trial. The primary outcome measure is non-union or avascular necrosis within 2 years. We now report fracture failures and reoperations within the first year. Patients and methods - Between May 2014 and February 2017, 439 patients were included in the study. They were above 50 years of age and treated for a femoral neck fracture at 9 orthopedic departments in Sweden. They were randomized to either Pinloc or Hansson pins. The fractures were grouped as (a) non-displaced regardless of age, (b) displaced in patients < 70 years, or (c) >= 70 years old, but deemed unfit to undergo arthroplasty. Follow-up with radiographs and outpatient visits were at 3 and 12 months. Failure was defined as early displacement/non-union, symptomatic segmental collapse, or deep infection. Results - 1-year mortality was 11%. Of the 325 undisplaced fractures, 12% (21/169) Pinloc and 13% (20/156) Hansson pin patients had a failure during the first year. The reoperation frequencies were 10% (16/169) and 8% (13/156) respectively. For the 75 patients 50-69 years old with displaced fractures, 11/39 failures occurred in the Pinloc group and 11/36 in the Hansson group, and 8/39 versus 9/36 patients were reoperated. Among those 39 patients >= 70 years old, 7/21 failures occurred in the Pinloc group and 4/18 in the Hansson group. Reoperation frequencies were 4/21 for Pinloc and 3/18 for the Hansson pin patients. No statistically significant differences were found in any of the outcomes between the Pinloc and Hansson groups. Interpretation - We found no advantages with Pinloc regarding failure or reoperation frequencies in this 1-year follow-up.
  •  
19.
  • Klingspor, L., et al. (author)
  • Epidemiology of fungaemia in Sweden: A nationwide retrospective observational survey
  • 2018
  • In: Mycoses. - : Wiley. - 0933-7407 .- 1439-0507. ; 61:10, s. 777-785
  • Journal article (peer-reviewed)abstract
    • ObjectivesTo identify the epidemiology and antifungal susceptibilities of Candida spp. among blood culture isolates to identify the epidemiology and antifungal susceptibilities of Candida spp. among blood culture isolates in Sweden. MethodsThe study was a retrospective, observational nationwide laboratory-based surveillance for fungaemia and fungal meningitis and was conducted from September 2015 to August 2016. ResultsIn total, 488 Candida blood culture isolates were obtained from 471 patients (58% males). Compared to our previous study, the incidence of candidaemia has increased from 4.2/100000 (2005-2006) to 4.7/100000 population/year (2015-2016). The three most common Candida spp. isolated from blood cultures were Candida albicans (54.7%), Candida glabrata (19.7%) and species in the Candida parapsilosis complex (9.4%). Candida resistance to fluconazole was 2% in C.albicans and between 0% and 100%, in non-albicans species other than C.glabrata and C.krusei. Resistance to voriconazole was rare, except for C.glabrata, C.krusei and C.tropicalis. Resistance to anidulafungin was 3.8% while no Candida isolate was resistant to amphotericin B. ConclusionsWe report an overall increase in candidaemia but a minor decrease of C.albicans while C.glabrata and C.parapsilosis remain constant over this 10-year period.
  •  
20.
  • Luhrig, Katharina, et al. (author)
  • Bacterial Community Analysis of Drinking Water Biofilms in Southern Sweden
  • 2015
  • In: Microbes and Environments. - 1342-6311. ; 30:1, s. 99-107
  • Journal article (peer-reviewed)abstract
    • Next-generation sequencing of the V1-V2 and V3 variable regions of the 16S rRNA gene generated a total of 674,116 reads that described six distinct bacterial biofilm communities from both water meters and pipes. A high degree of reproducibility was demonstrated for the experimental and analytical work-flow by analyzing the communities present in parallel water meters, the rare occurrence of biological replicates within a working drinking water distribution system. The communities observed in water meters from households that did not complain about their drinking water were defined by sequences representing Proteobacteria (82-87%), with 22-40% of all sequences being classified as Sphingomonadaceae. However, a water meter biofilm community from a household with consumer reports of red water and flowing water containing elevated levels of iron and manganese had fewer sequences representing Proteobacteria (44%); only 0.6% of all sequences were classified as Sphingomonadaceae; and, in contrast to the other water meter communities, markedly more sequences represented Nitrospira and Pedomicrobium. The biofilm communities in pipes were distinct from those in water meters, and contained sequences that were identified as Mycobacterium, Nocardia, Desulfovibrio, and Sulfuricurvum. The approach employed in the present study resolved the bacterial diversity present in these biofilm communities as well as the differences that occurred in biofilms within a single distribution system, and suggests that next-generation sequencing of 16S rRNA amplicons can show changes in bacterial biofilm communities associated with different water qualities.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 11-20 of 29
Type of publication
journal article (26)
conference paper (2)
book chapter (1)
Type of content
peer-reviewed (29)
Author/Editor
Rotter, Jerome I. (5)
Liu, Yongmei (5)
Hofman, Albert (5)
Uitterlinden, André ... (5)
Franco, Oscar H. (5)
Holmqvist, Kenneth (4)
show more...
Mangino, Massimo (4)
Samani, Nilesh J. (4)
Johansson, Roger (4)
Salomaa, Veikko (3)
Jula, Antti (3)
Perola, Markus (3)
Nasic, Salmir (3)
Wareham, Nicholas J. (3)
Johansson, Åsa (3)
Chasman, Daniel I. (3)
Amin, Najaf (3)
van Duijn, Cornelia ... (3)
Langenberg, Claudia (3)
Gieger, Christian (3)
Boomsma, Dorret I. (3)
Spector, Tim D. (3)
Jarvelin, Marjo-Riit ... (3)
Knekt, Paul (3)
Luan, Jian'an (3)
Eriksson, Johan G. (3)
Schmidt, Reinhold (3)
Schmidt, Helena (3)
Zhao, Jing Hua (3)
Manichaikul, Ani (3)
Harris, Tamara B (3)
Loos, Ruth J F (3)
Harris, Sarah E (3)
Starr, John M (3)
Morrison, Alanna C (3)
Psaty, Bruce M (3)
Vitart, Veronique (3)
Elliott, Paul (3)
Gudnason, Vilmundur (3)
Hwang, Shih-Jen (3)
Arking, Dan E. (3)
van der Harst, Pim (3)
Hottenga, Jouke-Jan (3)
Esko, Tõnu (3)
Raitakari, Olli (3)
Vollenweider, Peter (3)
Oscarsson, Martin (3)
Kristiansson, Kati (3)
Teumer, Alexander (3)
Milaneschi, Yuri (3)
show less...
University
Uppsala University (11)
Lund University (11)
University of Gothenburg (10)
Karolinska Institutet (6)
Umeå University (5)
Royal Institute of Technology (2)
show more...
Stockholm University (2)
Linköping University (2)
Chalmers University of Technology (1)
Karlstad University (1)
show less...
Language
English (29)
Research subject (UKÄ/SCB)
Medical and Health Sciences (16)
Natural sciences (8)
Social Sciences (3)
Engineering and Technology (2)
Humanities (2)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view